Delayed cell death signaling in traumatized central nervous system: Hypoxia

Neurochemical Research

Volumn 27, Issue 1-2, 2002, Pages 97-106

  Chu, D ^a   Qiu, J ^a   Grafe, M ^a   Fabian, R ^a   Kent, T A ^a   Rassin, D ^a   Nesic, O ^a   Werrbach Perez, K ^a   Perez Polo, R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Apoptosis; Cells death; Hypoxia; Necrosis

Indexed keywords

HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL DEATH; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; CYTOPLASM; DNA DEGRADATION; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME REGULATION; HYPOXIA; NECROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD INJURY; STROKE;

ANIMALS; ANOXIA; APOPTOSIS; CELL DEATH; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; ISCHEMIA; NECROSIS; NEURONS; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES; TIME FACTORS;

EID: 0036129813     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014858707218     Document Type: Article

References (111)

1. "Apoptosis and necrosis sis after reversible focal ischemia: An in situ DNA fragmentation analysis"
2. Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis?
3. Induction of caspase-3-1ike protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia
4. Attenuation of delayed neuronal death after mild focal ischemic in mice by inhibition of the caspase family
5. Alterations of Bcl-2 family proteins precede cytoskeletal proteolysis in the penumbra, but not in infarct centres following focal cerebral ischemia in mice
6. Early and sequential recruitment of apoptosis effectors after focal permanent ischemic in mice
7. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis
8. Transient global forebrain ischemia induces a prolonged expression of the caspase-3 mRNA in rat hippocampal CA1 pyramidal neurons
9. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis
10. Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia
11. Apoptosis, excitotoxicity, and neuropathology
12. Poly(ADP-ribose) polymerase, nitric oxide and cell death
13. Aponecrosis: Morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis
14. Cell death perinatal hypoxicischaemic brain injury
15. DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat
16. Dexamethasone prevents apoptosis in a neonatal rat model of hypoxic-ischemic encephalopathy (HIE) by a reactive oxygen species-independent mechanism
17. A model of transient unilateral focal ischemia with reperfusion in the P7 neonatal rat morphological changes indicative of apoptosis
18. Evidence of nuclear DNA fragmentation following hypoxia-ischemia in the infant rat brain, and transient forebrain ischemia in the adult gerbil
19. Excitotoxic neuronal death in the immature brain is an apoptosisnecrosis morphological continuum
20. Neuronal death in newborn striatum after hypoxia-ischemia is necrosis and evolves with oxidative stress
21. Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis
22. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: Evidence for apoptosis during selective neuronal loss
23. Neuronal death and survival in two models of hypoxic-ischemic brain damage
24. Nuclear condensation and fragmentation following cerebral hypoxiaischemia occurs more frequently in immature than older rats
25. Induction of Apoptosis Signal Regulating Kinase 1 (ASK 1) atler spinal cord injury in rats: Possible involvement of ASKI-JNK and -p38 pathway in neuronal apoptosis
26. Neuronal and glial apoptosis after traumatic spinal cord injury
27. Neuronal apoptosis and necrosis following spinal cord ischemia in the rat
28. Protection of rat spinal cord from ischemia with dextrohan and cycloheximide: Effects on necrosis and apoptosis
29. The temporal profile and morphologic features of neuronal death in human stroke resemble those observed in experimental forebrain ischemia: The potential role of apoptosis
30. Survival- and death-promoting events after transient cerebral ischemia: Phosphorylation of Akt, release of cytochrome C, and activation of caspase-like proteases
31. Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia
32. Reperfusion injury as the mechanism of brain damage after perinatal asphyxia
33. Oxidative stress in brain ischemia
34. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia
35. Oxidative metabolism, apoptosis and perinatal brain injury
36. Caspase inhibitor affords neoro-protection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury
37. Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats
38. Early detection of DNA strand breaks in the brain after transient focal ischemia: Impliations for the role of DNA damage in apoptosis and neuronal cell death
39. Neurotrophin Regulation of energy homeostasis in the central nervous system
40. Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer
41. The world according to PARP
42. Induction of DNA fragmentation after 10 to 120 min. of focal cerebral ischemla in rats
43. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
44. Evidence for DNA fragmentation in the CNS of aged fisher -344 rats
45. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks
46. Oxygen radicals in cerebral ischemia
47. Evidence for free radical production during reperfusion from global cerebral ischemia
48. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation
49. Initiation and propagation of lipid peroxidation in cerebral infarction models. Experimental studies
50. Free fatty acids in the rat brain in moderate and severe hypoxia
51. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol
52. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide
53. Repair of oxidative damage to nuclear and mitmchondrial DNA in mammalian cells
54. DNA damage and repair in central nervous system injury
55. Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain
56. Use of the moris water maze and acoustic startle chamber to evaluate neurologic injury after asphyxial arrest in rats
57. Poly(ADP-ribose) polymerase induction is an early signal of apoptosis in human neuroblastoma
58. A shuttle mechanism for DAN-protein interactions. The regulation of poly(ADP-ribose) polymerase
59. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
60. Cleavage of poly(ADP-ribose) polymerase: A sensitive parameter to study cell death
61. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis
62. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis
63. Cellular responses to DNA damage in the absence of poly(ADP-ribose) polymerase
64. Poly(ADP-ribose) polymerase-1 in the nervous system
65. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion
66. Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis
67. Poly(ADP-ribose) in the cellular response to DNA damage
68. Mice lacking ADPRT and poly ADP-ribosylation develop normally but are susceptible to skin disease
69. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and cells
70. Poly(ADP-ribose) polymerase-1: What have we learned from the deficient mouse model?
71. Apoptosis and expression of DNA repair proteins in ischaemic brain injury in man
72. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain
73. Neuronal accumulation of poly(ADP-ribose) after brain ischaemia
74. The neuroprotective effect of cerebral poly(ADP-ribose) polymerase inhibition in a rat model of global ischemia
75. Neuroprotective effects of inhibiting poly(ADP-ribose) synthase on focal cerebral ischemia in rats
76. Inhibition of poly(ADP-ribose) polymerase. Reduction of ischemic injury and attenuation of N-methyl-D-aspartate-induced neurotransmitter dysregulation
77. The effect of reperfusion on neuroprotection using an inhibitor of poly(ADP-ribose) polymerase
78. Poly(APD-ribose) polymerase gene disruption renders mice resistent to cerebral ischemia
79. Apoptosis in the absence of poly(ADP-ribose) polymerase
80. Cytochrome C is released from mitochondria into the cytosol after cerebral anoxia or ischemia
81. Alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation and IkappaBalpha degradation in human glioma cells and experimental brain inflammation
82. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons
83. In vivo Bcl-2 oncogene neuronal expression in the rat spinal cord
84. Apoptosis of Bcl-xL deficient telencephalic cells in vitro
85. Apoptosis and expression of Bcl-2 after compression trauma to rat spinal cord
86. Differential regulation of Bax, Bcl-2, and Bcl-x proteins in focal cortical ischemia in the rat
87. Constitutive NF-κB activity in neurons
88. Stimulation of ionotropic glutamate receptors activates transcription factor NF-κB in primary neurons
89. H202 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor
90. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NFκB and AP-1
91. Neuro-protection by aspirin and sodium salicylate through blockade of NF-κB activation
92. Central nervous system DNA fragmentation induced by the inhibition of nuclear factor Kappa B
93. Inhibition of nuclear factor kappa B (NFkappaB) activity induces nerve growth factor-resistant apoptosis in PCI2 cells
94. Bcl-2 and Bcl-2-related proteins in apoptosis regulation
95. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
96. BCL-2 protein expression in apoptosis: Oxidative stress versus serum deprivation in PC 12 cells
97. Cytokines and perinatal brain injury
98. Cerebral hypoxia-ischemia stimulates cytokine gene expression in the perinatal rats
99. The interleukin-I receptor antagonist (rhLI-Ira) protects against cerebral infarction in a rat model of hypoxia-isehemia
100. The role of neutrophits in the production of hypoxic-ischemic brain injury in the neonatal rat
101. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats
102. Inflammatory gene expression in cerebral ischemia and trauma
103. An in situ hybridization study on interleukin-1 beta mRNA induced by transient forebrain isehemia in the rat brain
104. Induction of interleukin-1 beta mRNA after focal cerebral ischaemia in the rat
105. Inflammatory mediators and neonatal brain damage
106. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats
107. Interleukin-4 and intefieukin-10 regulate IL1-beta induced mouse primary astrocyte activation: A comparative study
108. Developmentally regulated gene expression of Th2 cytokines in the brain
109. Infection and pretern birth evidence of a common causal relationship with bronchopulmonary dysplasia and cerebral palsy
110. Cytokine response in cerebrospinal fluid after birth asphyxia
111. Brain damage in pretern newborns: Might enhancement of developmentally regulated endogenous protection open a door for prevention?